Page last updated: 2024-08-24

triazoles and Graft vs Host Disease

triazoles has been researched along with Graft vs Host Disease in 76 studies

Research

Studies (76)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	28 (36.84)	29.6817
2010's	46 (60.53)	24.3611
2020's	2 (2.63)	2.80

Authors

Authors	Studies
Anguita, J; Bailén, R; Balsalobre, P; Buño, I; Diez-Martin, JL; Dorado, N; Guinea, J; Kwon, M; Machado, M; Oarbeascoa, G; Padilla, B; Pradillo, V; Sancho, M; Serrano, D	1
Beilhack, A; Chen, CW; Dees, C; Distler, JHW; Ditschkowski, M; Dreißigacker, K; Herr, W; Karrer, S; Krauss, S; Mackensen, A; Matei, AE; Meng, X; Schett, G; Shen, L; Spriewald, BM; Tran-Manh, C; Trinh-Minh, T; Winkler, J; Wolff, D; Zhang, Y; Zhu, H; Ziemer, M	1
Aragón, B; Cámara, R; Gozalbo, I; Grau, S; Jurado, M; Sanz, J	1
Feng, S; Han, M; He, Y; Jiang, E; Liu, L; Wang, Z; Wei, J; Yang, D; Zhai, W; Zhang, G; Zhang, L; Zhang, R; Zhang, S	1
Chauvin, C; Chevallier, P; Dalichampt, M; Deslandes, G; Garnier, A; Gastinne, T; Guillaume, T; Le Bourgeois, A; Le Gouill, S; Moreau, P; Paré, M; Pere, M; Peterlin, P	1
Abzug, MJ; Curtis, D; Hurst, AL; Strommen, A	1
Dadwal, S; Jhangiani, K; Kieu, V; Nakamura, R; Pon, D	1
Collins, J; Lee, P; Parsad, S; Plach, K; Shea, K	1
Feng, WY; Hu, L; Huang, L; Li, TF; Liu, XM; Luo, XX; Ma, XL; Wu, CF	1
Balabanian, K; Bourgeade, M; Duclos-Vallee, JC; Haïm-Boukobza, S; Perlemuter, G; Roque-Afonso, AM; Teicher, E	1
Adeyemi, O; Clagett, B; Dahl, V; Deeks, SG; Funderburg, NT; Gilman, LE; Hayes, TL; Hunt, PW; Landay, AL; Lederman, MM; Martin, JN; McLaughlin, B; Palmer, S; Rodriguez, B; Schacker, TW; Shacklett, BL; Shulman, NS; Somsouk, M	1
Huang, JT; Margossian, SP; Nambudiri, VE; Rork, JF	1
McNeil, C	1
Autran, B; Barbuat, C; Corbeau, P; Cuzin, L; Flandre, P; Ghosn, J; Lascoux-Combe, C; Lavigne, JP; Psomas, C; Reynes, J; Trabelsi, S	1
Deeks, SG; Hunt, PW; Lederman, MM	1
Bierings, MB; Boelens, JJ; Gerhardt, CE; Hol, JA; Lindemans, CA; Versluys, AB; Wildt de, A; Wolfs, TF	1
Adamski, Z; Gil, L; Komarnicki, M; Kubisiak-Michalska, A; Kubisiak-Rzepczyk, H; Mol, A; Reich, A; Zawirska, A	1
Blennow, O; El-Serafi, I; Eliasson, E; Hassan, M; Mattsson, J; Pettersson, T; Pohanka, A; Ringdén, O; Szakos, A	1
Chen, SC; Gilroy, NM; Morrissey, CO; Slavin, MA; Szer, J; Tam, CS; Thursky, KA; van Hal, SJ; Worth, LJ	1
Liu, W; Ren, HY; Shi, YJ; Yuan, J	1
Han, M; Huang, H; Huang, X; Ji, Y; Meng, F; Ren, H; Shen, Z; Sun, Y; Wang, C; Wu, D; Yu, L; Zhang, X	1
Ganetsky, A; Hughes, ME; Miano, TA; Porter, DL; Reshef, R; Vonderheide, RH	1
Blanco, JR; Ochoa-Callejero, L	1
Dong, Y; Liu, H; Liu, W; Miao, S; Ren, H; Shi, Y; Tang, B; Yin, Y	1
Davies, SM; Fukuda, T; Kashuba, ADM; Khandelwal, P; Marsh, RA; Mehta, PA; Mizuno, K; Teusink-Cross, A; Vinks, AA	1
Bouza, E; Escribano, P; Guinea, J; Montilla, P; Muñoz, P; Padilla, B	1
Atilla, E; Demirer, T; Toprak, SK	1
Bateman, AC; Clarridge, J; Garvin, K; Greenbaum, A; Grim, J; Liu, AW	1
Benesch, M; Dornbusch, HJ; Lackner, H; Schwinger, W; Sovinz, P; Strenger, V; Urban, C	1
Ahl, PL; Arseni, B; Battistini, L; Bonitz, S; Campo, S; Carminati, P; D'Alessio, V; De Santis, R; Di Mitri, D; Lu, R; Mannino, R; Ngoje, J; Rossi, S; Ruggiero, V	1
Farmen, S; Kaul, DR; Khaled, YA; Lowe, L; Visvesvara, GS; Yanik, GA	1
Imai, K; Kobayashi, D; Kogawa, K; Nonoyama, S; Nozaki, M; Sugita, T; Tokimatsu, I; Tsuji, Y	1
Baird, K; Cowen, EW; Gea-Banacloche, J; Mitchell, S; Patel, AR; Pavletic, SZ; Turner, ML; Wise, B	1
Anasetti, C; Field, T; Gergis, U; Greene, J; Huang, Y; Kharfan-Dabaja, M; Markey, K; Perkins, J; Schell, MJ; Wetzstein, G	1
Carreras, E; Casado, MA; de la Cámara, R; Grau, S; Jarque, I; Sabater, FJ; Sanz, MA	1
Higuchi, T; Kako, S; Kanda, Y; Kimura, S; Nakasone, H; Nishida, J; Okuda, S; Oshima, K; Sato, K; Sato, M; Tanaka, Y; Tanihara, A; Terasako, K; Yamazaki, R	1
Bug, G; Heinz, WJ; Mousset, S; Rickerts, V; Tintelnot, K	1
Amigues, I; Barker, J; Chung, D; Cohen, N; Jakubowski, A; Papanicolaou, GA; Plescia, C; Seo, SK	1
Ambrosioni, J; Garbino, J; Gumy-Pause, F; Myers, C	1
Jansen, JP; Janssen, JJ; Lugtenburg, E; O'Sullivan, AK; Span, LF; Stam, WB	1
Greiner, RA; Imhof, A; Meier, Y; O'Sullivan, AK; Papadopoulos, G	1
Colangelo, PM; Gobburu, JV; Jang, SH	1
Langston, AA; Mehta, AK	1
Andreesen, R; Hahn, J; Holler, E; Reichle, A; Stifel, F	1
Alvarez, MA; Gómez, P; Martín, C; Martín, V; Martínez, F; Molina, JR; Rodríguez, G; Rodríguez-Villa, A; Rojas, R; Sánchez-García, J; Serrano, J; Tallón, D; Torres, A	1
Asslaber, M; Buzina, W; Haas, D; Heiling, B; Hoenigl, M; Koidl, C; Krause, R; Neumeister, P; Pichler, M; Rohn, A; Salzer, HJ; Valentin, T; Zollner-Schwetz, I	1
Cleary, JD; DeShazo, M; Jenkins, J; Songcharoen, S	1
Antin, JH; Armand, P; Baden, LR; Hammond, SP; Koo, S; Kubiak, DW; Marty, FM	1
Bailey, S; Emerson, SG; Frey, NV; Goldstein, SC; Heitjan, DF; Hexner, EO; Hoxie, JA; Loren, AW; Luger, SM; Mick, R; Nasta, SD; Porter, DL; Reshef, R; Smith, J; Stadtmauer, EA; Vonderheide, RH	1
Berruyer, AS; Bulabois, CE; Cahn, JY; Jourdil, JF; Stanke-Labesque, F; Thiébaut, A; Tonini, J	1
Girmenia, C; Iori, AP	1
Buendía, B; Cuenca-Estrella, M; De La Camara, R; Mellado, E; Rodriguez-Tudela, JL	1
Brower, V	1
Davies, JK; Gribben, JG	1
Cornely, OA; Karthaus, M; Ullmann, AJ	1
Bastié, JN; Bretagne, S; Castaigne, S; Chehata, S; Cordonnier, C; Kuentz, M; Maury, S; Pautas, C; Ribaud, P	1
Mehta, J; Trifilio, S; Verma, A; Williams, S; Zembower, T	1
Benjamin, DK; Jafri, H; Kontoyiannis, DP; Lionakis, MS; Lutsar, I; Marr, KA; Perfect, JR; Steinbach, WJ; Torres, HA; Walsh, TJ	1
Bartelt, LA; de Magalhaes-Silverman, M; Diekema, DJ; Dodgson, KJ; Hoth, PL; Kilborn, SB; Pfaller, MA; Siwek, GT	1
Jagirdar, J; Scott, RS; Sutton, DA	1
Abe, F; Furukawa, H; Kawagishi, N; Kuramochi, H; Mashiba, H; Masuda, A; Matsumoto, S; Nemoto, K; Ono, M; Saiga, K; Tokunaka, K; Toyoda, E	1
Antin, JH; Baden, LR; Campbell, BJ; Cutler, CS; Fiumara, K; Lowry, CM; Marty, FM	1
Blijlevens, NM; Donnelly, JP; Klont, RR; van der Velden, WJ; Verweij, PE	1
Blackwood, RA; Klein, KC	1
Boparai, N; Chandrasekar, P; Durrant, S; Greinix, H; Langston, A; Lipton, JH; Morais de Azevedo, W; Patino, H; Pedicone, L; Reddy, V; Tarantolo, SR; Ullmann, AJ; Vesole, DH	1
De Pauw, BE; Donnelly, JP	1
Albring, J; Berdel, WE; Bisping, G; Kiehl, M; Kienast, J; Opitz, C; Pauels, HG; Poremba, C; Scheffold, C; Schlösser, V; Silling, G; Specht, C; Stelljes, M; Volkmann, S	1
Krause, DS	1
Hosoki, T; Ikuta, K; Jimbo, J; Kohgo, Y; Nishimura, K; Sano, A; Sato, K; Shindo, M; Torimoto, Y	1
Handke, R; Peleg, AY; Slavin, M; Szer, J; Tong, SY; Yoong, J	1
Book, BK; Lemonte, A; Pescovitz, MD; Smedema, M; Wheat, LJ; Zhuang, D	1
Fung, HB; Schiller, DS	1
Chandrasekar, P; Krishna, G; Martinho, M; Patino, H; Ullmann, AJ	1
Conlon, JD; Dauenhauer, M; Drolet, BA; Fairley, JA; Margolis, D; Talano, J; Tonkovic-Capin, V	1
Herbrecht, R; Ribaud, P; Schlamm, HT; Wingard, JR	1
Akiyama, T; Fujimi, A; Hirayama, Y; Kato, J; Kogawa, K; Kon, S; Konuma, Y; Kuroda, H; Kusakabe, T; Lu, Y; Matsunaga, T; Niitsu, Y; Nishiie, K; Sakamaki, S; Takemoto, N	1

Reviews

7 review(s) available for triazoles and Graft vs Host Disease

Article	Year
Survey of antifungal prophylaxis and fungal diagnostic tests employed in malignant haematology and haemopoietic stem cell transplantation (HSCT) in Australia and New Zealand. Internal medicine journal, 2014, Volume: 44, Issue:12b Topics: Antifungal Agents; Aspergillosis; Australia; Chemoprevention; Consensus Development Conferences as Topic; Data Collection; Diagnostic Tests, Routine; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; New Zealand; Opportunistic Infections; Practice Guidelines as Topic; Pre-Exposure Prophylaxis; Triazoles	2014
Off-label use of maraviroc in clinical practice. Expert review of anti-infective therapy, 2016, Volume: 14, Issue:1 Topics: Animals; Arthritis, Rheumatoid; CCR5 Receptor Antagonists; Clinical Trials as Topic; Cyclohexanes; Graft vs Host Disease; Hematologic Neoplasms; HIV Fusion Inhibitors; HIV Infections; HIV-1; Humans; Maraviroc; Mice; Off-Label Use; Sarcoidosis; Triazoles	2016
Current Review of Iron Overload and Related Complications in Hematopoietic Stem Cell Transplantation. Turkish journal of haematology : official journal of Turkish Society of Haematology, 2017, Mar-01, Volume: 34, Issue:1 Topics: Benzoates; Deferasirox; Ferritins; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Iron Chelating Agents; Iron Overload; Survival Rate; Triazoles	2017
Use of posaconazole in the treatment of invasive fungal infections. Expert review of hematology, 2009, Volume: 2, Issue:6 Topics: Animals; Antifungal Agents; Clinical Trials as Topic; Drug Resistance, Fungal; Fungi; Graft vs Host Disease; Humans; Immunocompromised Host; Leukemia, Myeloid; Mice; Mycoses; Myelodysplastic Syndromes; Rabbits; Stem Cell Transplantation; Triazoles; United States	2009
Safety and interactions of new antifungals in stem cell transplant recipients. Expert opinion on drug safety, 2012, Volume: 11, Issue:5 Topics: Amphotericin B; Animals; Antifungal Agents; Drug Interactions; Echinocandins; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Mycoses; Opportunistic Infections; Pharmacovigilance; Renal Insufficiency; Stem Cell Transplantation; Triazoles	2012
Evidence-based assessment of primary antifungal prophylaxis in patients with hematologic malignancies. Blood, 2003, May-01, Volume: 101, Issue:9 Topics: Adrenal Cortex Hormones; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Clinical Trials as Topic; Disease Susceptibility; Drug Carriers; Evidence-Based Medicine; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Liposomes; Mycoses; Neutropenia; Recurrence; Risk Factors; Triazoles	2003
Posaconazole: an extended-spectrum triazole antifungal agent. Clinical therapeutics, 2007, Volume: 29, Issue:9 Topics: Administration, Oral; AIDS-Related Opportunistic Infections; Antifungal Agents; Aspergillosis; Candidiasis; Drug Resistance, Fungal; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Mycoses; Tissue Distribution; Triazoles	2007

Trials

10 trial(s) available for triazoles and Graft vs Host Disease

Article	Year
The immunologic effects of maraviroc intensification in treated HIV-infected individuals with incomplete CD4+ T-cell recovery: a randomized trial. Blood, 2013, Jun-06, Volume: 121, Issue:23 Topics: Adult; CCR5 Receptor Antagonists; CD4-Positive T-Lymphocytes; Cyclohexanes; Female; Gastrointestinal Tract; Graft vs Host Disease; HIV Fusion Inhibitors; HIV Infections; HIV-1; Humans; Immunophenotyping; Lymphocyte Activation; Lymphoid Tissue; Male; Maraviroc; Middle Aged; Rectum; RNA, Viral; Triazoles; Viral Load	2013
Lack of a significant pharmacokinetic interaction between maraviroc and tacrolimus in allogeneic HSCT recipients. The Journal of antimicrobial chemotherapy, 2015, Volume: 70, Issue:7 Topics: Adult; Aged; Cyclohexanes; Drug Interactions; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunologic Factors; Male; Maraviroc; Middle Aged; Prospective Studies; Tacrolimus; Transplantation, Homologous; Triazoles; Young Adult	2015
Pharmacokinetics of CsA during the switch from continuous intravenous infusion to oral administration after allogeneic hematopoietic stem cell transplantation. Bone marrow transplantation, 2010, Volume: 45, Issue:6 Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Area Under Curve; Biological Availability; Cyclosporine; Drug Synergism; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infusions, Intravenous; Male; Middle Aged; Pyrimidines; Transplantation, Homologous; Treatment Outcome; Triazoles; Voriconazole; Young Adult	2010
Economic evaluation of posaconazole versus fluconazole prophylaxis in patients with graft-versus-host disease (GVHD) in the Netherlands. Annals of hematology, 2010, Volume: 89, Issue:9 Topics: Adult; Double-Blind Method; Female; Fluconazole; Graft vs Host Disease; Humans; Male; Models, Economic; Netherlands; Quality-Adjusted Life Years; Triazoles	2010
Exposure-response of posaconazole used for prophylaxis against invasive fungal infections: evaluating the need to adjust doses based on drug concentrations in plasma. Clinical pharmacology and therapeutics, 2010, Volume: 88, Issue:1 Topics: Antifungal Agents; Antineoplastic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Graft vs Host Disease; Humans; Mycoses; Neutropenia; Stem Cell Transplantation; Treatment Outcome; Triazoles	2010
Voriconazole as primary antifungal prophylaxis in children undergoing allo-SCT. Bone marrow transplantation, 2012, Volume: 47, Issue:4 Topics: Acute Disease; Adolescent; Antifungal Agents; Child; Child, Preschool; Female; Graft vs Host Disease; Hematologic Diseases; Humans; Male; Mycoses; Pyrimidines; Stem Cell Transplantation; Time Factors; Triazoles; Voriconazole	2012
Blockade of lymphocyte chemotaxis in visceral graft-versus-host disease. The New England journal of medicine, 2012, Jul-12, Volume: 367, Issue:2 Topics: Adult; Aged; CCR5 Receptor Antagonists; Chemokine CCL3; Chemokine CCL5; Chemotaxis, Leukocyte; Cyclohexanes; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Kaplan-Meier Estimate; Male; Maraviroc; Middle Aged; T-Lymphocytes; Transplantation, Homologous; Triazoles; Young Adult	2012
Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. The New England journal of medicine, 2007, Jan-25, Volume: 356, Issue:4 Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Double-Blind Method; Female; Fluconazole; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Mycoses; Opportunistic Infections; Risk Factors; Triazoles	2007
Pharmacokinetics of oral posaconazole in allogeneic hematopoietic stem cell transplant recipients with graft-versus-host disease. Pharmacotherapy, 2007, Volume: 27, Issue:12 Topics: Acute Disease; Adolescent; Adult; Age Factors; Aged; Antifungal Agents; Body Weight; Chronic Disease; Diarrhea; Double-Blind Method; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mycoses; Opportunistic Infections; Racial Groups; Sex Factors; Transplantation, Homologous; Triazoles	2007
Changes in causes of death over time after treatment for invasive aspergillosis. Cancer, 2008, May-15, Volume: 112, Issue:10 Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Cause of Death; Graft vs Host Disease; Humans; Neoplasms; Pyrimidines; Survival Rate; Time Factors; Triazoles; Voriconazole	2008

Other Studies

59 other study(ies) available for triazoles and Graft vs Host Disease

Article	Year
Successful Treatment of Severe Aspergillosis with Isavuconazole Therapy after Allogeneic Stem Cell Transplantation. Chemotherapy, 2019, Volume: 64, Issue:2 Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; DNA, Fungal; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Nitriles; Pyridines; Thorax; Transplantation, Homologous; Triazoles	2019
Targeting of canonical WNT signaling ameliorates experimental sclerodermatous chronic graft-versus-host disease. Blood, 2021, 04-29, Volume: 137, Issue:17 Topics: Animals; Anti-Bacterial Agents; Female; Fibroblasts; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Middle Aged; Pyrans; Pyrvinium Compounds; Scleroderma, Systemic; Sulfones; Triazoles; Wnt Signaling Pathway	2021
Cost-effectiveness of posaconazole tablets versus fluconazole as prophylaxis for invasive fungal diseases in patients with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. The European journal of health economics : HEPAC : health economics in prevention and care, 2018, Volume: 19, Issue:4 Topics: Antifungal Agents; Cost-Benefit Analysis; Female; Fluconazole; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Mycoses; Spain; Tablets; Triazoles	2018
Efficacy and safety of posaconazole in hematopoietic stem cell transplantation patients with invasive fungal disease. Future microbiology, 2017, Volume: 12 Topics: Adult; Antifungal Agents; Cytomegalovirus Infections; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Invasive Fungal Infections; Male; Middle Aged; Multivariate Analysis; Neutropenia; Primary Prevention; Regression Analysis; Retrospective Studies; Steroids; Time Factors; Transplantation Conditioning; Treatment Outcome; Triazoles	2017
Fungal Prophylaxis with a Gastro-Resistant Posaconazole Tablet for Patients with Hematological Malignancies in the POSANANTES Study. Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:2 Topics: Adult; Aged; Antibiotic Prophylaxis; Antifungal Agents; Female; Fungi; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Invasive Fungal Infections; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Stomach; Tablets; Triazoles; Young Adult	2018
Use of Intravenous Posaconazole in Hematopoietic Stem Cell Transplant Patients. Journal of pediatric hematology/oncology, 2018, Volume: 40, Issue:4 Topics: Administration, Intravenous; Allografts; Child; Gastrointestinal Diseases; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Mucositis; Triazoles	2018
Effect of isavuconazole on tacrolimus and sirolimus serum concentrations in allogeneic hematopoietic stem cell transplant patients: A drug-drug interaction study. Transplant infectious disease : an official journal of the Transplantation Society, 2019, Volume: 21, Issue:1 Topics: Adult; Aged; Antifungal Agents; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Nitriles; Pyridines; Retrospective Studies; Sirolimus; Tacrolimus; Transplantation, Homologous; Triazoles; Young Adult	2019
The impact of initiating posaconazole on tacrolimus pharmacokinetics in allogeneic stem cell transplantation. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2020, Volume: 26, Issue:1 Topics: Adult; Antifungal Agents; Drug Administration Schedule; Drug Interactions; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Retrospective Studies; Stem Cell Transplantation; Tacrolimus; Triazoles	2020
Population pharmacokinetics of cyclosporine in Chinese children receiving hematopoietic stem cell transplantation. Acta pharmacologica Sinica, 2019, Volume: 40, Issue:12 Topics: Adolescent; Antifungal Agents; Asian People; Body Weight; Child; Child, Preschool; Cyclosporine; Cytochrome P-450 CYP3A; Drug Monitoring; Female; Glomerular Filtration Rate; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Male; Models, Biological; Polymorphism, Genetic; Transplantation, Homologous; Triazoles	2019
Blockade of CCR5 to protect the liver graft in HIV/HCV co-infected patients. Journal of hepatology, 2013, Volume: 59, Issue:3 Topics: CCR5 Receptor Antagonists; Chemotaxis, Leukocyte; Cyclohexanes; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; T-Lymphocytes; Triazoles	2013
Nonmelanoma skin cancer in childhood after hematopoietic stem cell transplant: a report of 4 cases. Journal of pediatric hematology/oncology, 2014, Volume: 36, Issue:3 Topics: Adolescent; Adult; Antifungal Agents; Boston; Carcinoma, Squamous Cell; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Incidence; Male; Neoplasm Staging; Prognosis; Pyrimidines; Risk Factors; Skin Neoplasms; Survival Rate; Survivors; Triazoles; Voriconazole; Whole-Body Irradiation; Young Adult	2014
Preventing graft-versus-host disease: transplanters glimpse hope beyond immunosuppressants. Journal of the National Cancer Institute, 2013, Jul-03, Volume: 105, Issue:13 Topics: Acute Disease; Bone Marrow Transplantation; Boronic Acids; Bortezomib; Chronic Disease; Clinical Trials as Topic; Cyclohexanes; Cyclophosphamide; Cyclosporine; Evidence-Based Medicine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Hydroxamic Acids; Immunosuppressive Agents; Maraviroc; Methotrexate; Pentostatin; Peripheral Blood Stem Cell Transplantation; Pyrazines; Quality of Life; Tacrolimus; Triazoles; Vorinostat	2013
Maraviroc-induced decrease in circulating bacterial products is not linked to an increase in immune activation in HIV-infected individuals. Blood, 2013, Sep-26, Volume: 122, Issue:13 Topics: CD4-Positive T-Lymphocytes; Cyclohexanes; Female; Graft vs Host Disease; HIV Infections; HIV-1; Humans; Male; Triazoles; Viral Load	2013
Response: Maraviroc intensification and microbial translocation. Blood, 2013, Sep-26, Volume: 122, Issue:13 Topics: CD4-Positive T-Lymphocytes; Cyclohexanes; Female; Graft vs Host Disease; HIV Infections; HIV-1; Humans; Male; Triazoles; Viral Load	2013
Predictors of invasive fungal infection in pediatric allogeneic hematopoietic SCT recipients. Bone marrow transplantation, 2014, Volume: 49, Issue:1 Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Child; Child, Preschool; Echinocandins; Female; Fusariosis; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infant; Lipopeptides; Logistic Models; Male; Mycoses; Neutrophils; Prospective Studies; Pyrimidines; Retrospective Studies; Risk; Treatment Outcome; Triazoles; Voriconazole; Young Adult	2014
Scedosporium prolificans fungaemia in a patient with acute lymphoblastic leukaemia. Journal de mycologie medicale, 2013, Volume: 23, Issue:4 Topics: Allografts; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Drug Substitution; Fatal Outcome; Female; Fluconazole; Fungemia; Graft vs Host Disease; Humans; Immunocompromised Host; Immunosuppressive Agents; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Scedosporium; Triazoles; Voriconazole; Young Adult	2013
Posaconazole concentrations in human tissues after allogeneic stem cell transplantation. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:8 Topics: Antifungal Agents; Autopsy; Brain Chemistry; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Kidney; Liver; Lung; Mycoses; Myocardium; Transplantation, Homologous; Triazoles	2014
Prophylaxis of acute graft-versus-host disease by CCR5 blockade combined with cyclosporine A in a murine model. Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2015, Volume: 64, Issue:2 Topics: Animals; CCR5 Receptor Antagonists; Cyclohexanes; Cyclosporine; Cytokines; Disease Models, Animal; Drug Synergism; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Immunosuppressive Agents; Intestines; Liver; Male; Maraviroc; Mice, Inbred BALB C; Mice, Inbred C57BL; Receptors, CCR5; Receptors, CCR7; Receptors, CXCR3; Triazoles	2015
Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2015, Volume: 21, Issue:6 Topics: Adolescent; Adult; Antifungal Agents; China; Chronic Disease; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Male; Mycoses; Myeloablative Agonists; Neutropenia; Prognosis; Prospective Studies; Risk Factors; Siblings; Survival Analysis; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; Treatment Outcome; Triazoles; Unrelated Donors	2015
CCR5 blockade combined with cyclosporine A attenuates liver GVHD by impairing T cells function. Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2016, Volume: 65, Issue:11 Topics: Animals; CCR5 Receptor Antagonists; Cyclohexanes; Cyclosporine; Cytokines; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Immunosuppressive Agents; Liver; Male; Maraviroc; Mice, Inbred BALB C; Mice, Inbred C57BL; Receptors, CCR5; T-Lymphocytes; Triazoles	2016
A Pharmacokinetic and Pharmacodynamic Study of Maraviroc as Acute Graft-versus-Host Disease Prophylaxis in Pediatric Allogeneic Stem Cell Transplant Recipients with Nonmalignant Diagnoses. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2016, Volume: 22, Issue:10 Topics: Acute Disease; Child; Child, Preschool; Cyclohexanes; Drug Administration Schedule; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Maraviroc; Premedication; Prospective Studies; Receptors, CCR5; Transplantation Conditioning; Treatment Outcome; Triazoles; Viscera	2016
Genotyping of Aspergillus fumigatus Reveals Compartmentalization of Genotypes in Disseminated Disease after Invasive Pulmonary Aspergillosis. Journal of clinical microbiology, 2017, Volume: 55, Issue:1 Topics: Adrenal Cortex Hormones; Adult; Antifungal Agents; Aspergillus fumigatus; Female; Genotype; Graft vs Host Disease; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Lung; Male; Microbial Sensitivity Tests; Microsatellite Repeats; Molecular Typing; Mycological Typing Techniques; Triazoles; Voriconazole	2017
Cutaneous phaeohyphomycosis in a hematopoietic stem cell transplant patient caused by Alternaria rosae: First case report. Transplant infectious disease : an official journal of the Transplantation Society, 2017, Volume: 19, Issue:3 Topics: Acute Kidney Injury; Acyclovir; Aged; Alternaria; Alternariosis; Antibiotic Prophylaxis; Antifungal Agents; Drug Therapy, Combination; Fatal Outcome; Graft vs Host Disease; Hand; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Levofloxacin; Magnetic Resonance Imaging; Male; Microbial Sensitivity Tests; Paranasal Sinuses; Phaeohyphomycosis; Pneumonia; Prednisone; Primary Myelofibrosis; Respiratory Insufficiency; Spores, Fungal; Transplantation, Homologous; Triazoles; Voriconazole	2017
Effective management of pulmonary aspergillosis invading the thoracic spine in a child with high risk ALL requiring allogeneic bone marrow transplantation. Medical mycology, 2008, Volume: 46, Issue:5 Topics: Adoptive Transfer; Amphotericin B; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Bone Marrow Transplantation; Caspofungin; Child; Echinocandins; Female; Graft vs Host Disease; Granulocytes; Humans; Lipopeptides; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Radiography, Thoracic; Spine; Triazoles; Voriconazole	2008
Efficacy of a nanocochleate-encapsulated 3,5-diaryl-s-triazole derivative in a murine model of graft-versus-host disease. Transplantation, 2008, Jul-15, Volume: 86, Issue:1 Topics: Administration, Oral; Anemia; Animals; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Chemokines; Disease Models, Animal; Drug Compounding; Female; Graft vs Host Disease; Hematologic Tests; Immunosuppressive Agents; Mice; Mice, Inbred C57BL; Nanocapsules; Time Factors; Triazoles	2008
Acanthamoeba infection in a patient with chronic graft-versus-host disease occurring during treatment with voriconazole. Transplant infectious disease : an official journal of the Transplantation Society, 2008, Volume: 10, Issue:6 Topics: Acanthamoeba; Amebiasis; Animals; Antifungal Agents; Antiprotozoal Agents; Drug Therapy, Combination; Encephalitis; Fatal Outcome; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Lung; Male; Middle Aged; Phosphorylcholine; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Skin; Triazoles; Voriconazole	2008
Quantitative PCR assay used to monitor serum Trichosporon asahii DNA concentrations in disseminated trichosporonosis. The Pediatric infectious disease journal, 2008, Volume: 27, Issue:11 Topics: Adolescent; Antifungal Agents; Antigens, Fungal; Bone Marrow Transplantation; DNA, Fungal; Graft vs Host Disease; Humans; Immunocompromised Host; Latex Fixation Tests; Male; Microbial Sensitivity Tests; Mycoses; Polymerase Chain Reaction; Polysaccharides; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Triazoles; Trichosporon; Voriconazole	2008
Voriconazole-induced phototoxicity masquerading as chronic graft-versus-host disease of the skin in allogeneic hematopoietic cell transplant recipients. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2009, Volume: 15, Issue:3 Topics: Adolescent; Adult; Antifungal Agents; Child; Dermatitis, Phototoxic; Diagnosis, Differential; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole	2009
Voriconazole provides effective prophylaxis for invasive fungal infection in patients receiving glucocorticoid therapy for GVHD. Bone marrow transplantation, 2010, Volume: 45, Issue:4 Topics: Adult; Antifungal Agents; Chemoprevention; Female; Fluconazole; Glucocorticoids; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole	2010
Economic evaluation of posaconazole vs fluconazole in the prevention of invasive fungal infections in patients with GVHD following haematopoietic SCT. Bone marrow transplantation, 2010, Volume: 45, Issue:5 Topics: Antifungal Agents; Cost-Benefit Analysis; Fluconazole; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Multivariate Analysis; Mycoses; Sensitivity and Specificity; Treatment Outcome; Triazoles	2010
Breakthrough zygomycosis on posaconazole prophylaxis after allogeneic stem cell transplantation. Transplant infectious disease : an official journal of the Transplantation Society, 2010, Volume: 12, Issue:3 Topics: Amphotericin B; Antifungal Agents; Chemoprevention; Drug Therapy, Combination; Fatal Outcome; Graft vs Host Disease; Humans; Lung Diseases, Fungal; Male; Middle Aged; Mucormycosis; Pneumonia; Rhizopus; Stem Cell Transplantation; Transplantation, Homologous; Triazoles	2010
Hepatic safety of voriconazole after allogeneic hematopoietic stem cell transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2010, Volume: 16, Issue:1 Topics: Adult; Antifungal Agents; Chemical and Drug Induced Liver Injury; Child; Cohort Studies; Drug Monitoring; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Liver; Liver Function Tests; Lymphocyte Depletion; Male; Opportunistic Infections; Pyrimidines; Retrospective Studies; Risk Factors; Statistics as Topic; T-Lymphocytes; Triazoles; Voriconazole	2010
Report of a successful treatment of pulmonary Cunninghamella bertholletiae infection with liposomal amphotericin and posaconazole in a child with GvHD and review of the literature. Journal of pediatric hematology/oncology, 2010, Volume: 32, Issue:2 Topics: Amphotericin B; Bone Marrow Transplantation; Child; Cunninghamella; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Lung Diseases, Fungal; Mucormycosis; Triazoles	2010
Cost-effectiveness of posaconazole compared with standard azole therapy for prevention of invasive fungal infections in patients at high risk in Switzerland. Oncology, 2010, Volume: 78, Issue:3-4 Topics: Cost-Benefit Analysis; Decision Support Techniques; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Markov Chains; Models, Theoretical; Mycoses; Myelodysplastic Syndromes; Neutropenia; Risk; Switzerland; Treatment Outcome; Triazoles	2010
Clinical experience with posaconazole prophylaxis--a retrospective analysis in a haematological unit. Mycoses, 2011, Volume: 54 Suppl 1 Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Female; Graft vs Host Disease; Hematology; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Retrospective Studies; Stem Cell Transplantation; Triazoles; Young Adult	2011
Disseminated Geosmithia argillacea infection in a patient with gastrointestinal GvHD. Bone marrow transplantation, 2012, Volume: 47, Issue:5 Topics: Amphotericin B; Antibodies, Monoclonal; Antifungal Agents; Eurotiales; Fatal Outcome; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infliximab; Lung Diseases, Fungal; Male; Pyrimidines; Triazoles; Voriconazole	2012
T. asahii pulmonary infection as a complication of TNF-inhibitor and steroids: posaconazole pharmacotherapy and risk analysis. Journal of the Mississippi State Medical Association, 2011, Volume: 52, Issue:11 Topics: Adalimumab; Adolescent; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antifungal Agents; Arthritis, Rheumatoid; Female; Glucocorticoids; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infliximab; Lung Diseases, Fungal; Male; Middle Aged; Risk Assessment; Risk Factors; Root Cause Analysis; Triazoles; Trichosporonosis; Tumor Necrosis Factor Inhibitors; Young Adult	2011
Safety of posaconazole and sirolimus coadministration in allogeneic hematopoietic stem cell transplants. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2012, Volume: 18, Issue:9 Topics: Adult; Antifungal Agents; Drug Administration Schedule; Drug Dosage Calculations; Drug Synergism; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycoses; Sirolimus; Transplantation, Homologous; Triazoles	2012
Therapeutic drug monitoring of posaconazole in allogeneic hematopoietic stem cell transplantation patients who develop gastrointestinal graft-versus-host disease. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Female; Gastrointestinal Diseases; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Retrospective Studies; Triazoles	2012
Breakthrough pulmonary Aspergillus fumigatus infection with multiple triazole resistance in a Spanish patient with chronic myeloid leukemia. Revista iberoamericana de micologia, 2013, Jan-03, Volume: 30, Issue:1 Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillus fumigatus; Caspofungin; Combined Modality Therapy; Cytochrome P-450 Enzyme System; Drug Resistance, Multiple, Fungal; Echinocandins; Fatal Outcome; Female; Fungal Proteins; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lipopeptides; Point Mutation; Postoperative Complications; Pulmonary Aspergillosis; Recurrence; Spain; Species Specificity; Transplantation Conditioning; Transplantation, Homologous; Triazoles	2013
Chemokine receptor blockade in graft-versus-host disease. The Lancet. Oncology, 2012, Volume: 13, Issue:8 Topics: CCR5 Receptor Antagonists; Cyclohexanes; Graft vs Host Disease; Humans; Immunologic Factors; Maraviroc; Stem Cell Transplantation; Treatment Outcome; Triazoles	2012
Blockade of chemotaxis in graft-versus-host disease. The New England journal of medicine, 2012, 10-25, Volume: 367, Issue:17 Topics: CCR5 Receptor Antagonists; Chemotaxis, Leukocyte; Cyclohexanes; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; T-Lymphocytes; Triazoles	2012
Secondary antifungal prophylaxis with voriconazole to adhere to scheduled treatment in leukemic patients and stem cell transplant recipients. Bone marrow transplantation, 2004, Volume: 33, Issue:9 Topics: Adolescent; Adult; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Female; Graft vs Host Disease; Humans; Leukemia; Male; Middle Aged; Prognosis; Prospective Studies; Pyrimidines; Recurrence; Risk; Stem Cell Transplantation; Transplantation, Homologous; Triazoles; Voriconazole	2004
Successful treatment of concomitant pulmonary zygomycosis and aspergillosis with a combination of amphotericin B lipid complex, caspofungin, and voriconazole in a patient on immunosuppression for chronic graft-versus-host disease. Bone marrow transplantation, 2004, Volume: 33, Issue:10 Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Chronic Disease; Drug Therapy, Combination; Echinocandins; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Lipopeptides; Lung; Middle Aged; Peptides, Cyclic; Pyrimidines; Tomography, X-Ray Computed; Transplantation, Homologous; Treatment Outcome; Triazoles; Voriconazole; Zygomycosis	2004
Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Jul-15, Volume: 39, Issue:2 Topics: Antifungal Agents; Aspergillosis; Cohort Studies; Female; Graft vs Host Disease; Humans; Logistic Models; Male; Proportional Hazards Models; Pyrimidines; Retrospective Studies; Survival Rate; Triazoles; Voriconazole	2004
Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Aug-15, Volume: 39, Issue:4 Topics: Adult; Antifungal Agents; Female; Fungi; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Pyrimidines; Rhizopus; Triazoles; Voriconazole; Zygomycosis	2004
Lung infection due to opportunistic fungus, Phialemonium obovatum, in a bone marrow transplant recipient: an emerging infection with fungemia and Crohn disease-like involvement of the gastrointestinal tract. Annals of diagnostic pathology, 2005, Volume: 9, Issue:4 Topics: Amphotericin B; Antifungal Agents; Ascomycota; Bone Marrow Transplantation; Drug Resistance, Fungal; Fungemia; Gastrointestinal Diseases; Graft vs Host Disease; Granuloma; Humans; Immunocompromised Host; Itraconazole; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lung Diseases, Fungal; Male; Middle Aged; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole	2005
NK026680, a novel compound suppressive of dendritic cell function, ameliorates mortality in acute lethal graft-versus-host reaction in mice. Bone marrow transplantation, 2006, Volume: 37, Issue:3 Topics: Administration, Oral; Animals; Antigens, CD; B7-2 Antigen; CD83 Antigen; Dendritic Cells; Gene Expression Regulation; Graft vs Host Disease; Histocompatibility Antigens Class I; Histocompatibility Antigens Class II; Humans; Immunoglobulins; Immunologic Factors; Interleukin-12; Interleukin-12 Subunit p35; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Mice, Transgenic; Molecular Structure; Protein Subunits; Pyrimidines; Triazoles	2006
Voriconazole and sirolimus coadministration after allogeneic hematopoietic stem cell transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2006, Volume: 12, Issue:5 Topics: Adult; Antifungal Agents; Cord Blood Stem Cell Transplantation; Creatinine; Dose-Response Relationship, Drug; Drug Evaluation; Drug Interactions; Female; Graft Rejection; Graft vs Host Disease; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Leukemia; Lipids; Male; Middle Aged; Mycoses; Peripheral Blood Stem Cell Transplantation; Postoperative Complications; Pyrimidines; Retrospective Studies; Sirolimus; Transplantation, Homologous; Triazoles; Voriconazole	2006
Primary hepatic invasive aspergillosis with progression after rituximab therapy for a post transplantation lymphoproliferative disorder. Annals of hematology, 2006, Volume: 85, Issue:9 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Chemical and Drug Induced Liver Injury; Fatal Outcome; Female; Galactose; Graft vs Host Disease; Humans; Liver Diseases; Lymphoproliferative Disorders; Mannans; Middle Aged; Pyrimidines; Rituximab; Splenic Diseases; Stem Cell Transplantation; Transplantation, Homologous; Triazoles; Voriconazole	2006
Topical voriconazole solution for cutaneous aspergillosis in a pediatric patient after bone marrow transplant. Pediatrics, 2006, Volume: 118, Issue:2 Topics: Administration, Cutaneous; Adult; Amphotericin B; Anemia, Aplastic; Antifungal Agents; Aspergillosis; Aspergillus flavus; Bone Marrow Transplantation; Combined Modality Therapy; Debridement; Dermatomycoses; Disease Susceptibility; Female; Graft vs Host Disease; Humans; Immunocompromised Host; Injections, Subcutaneous; Nystatin; Postoperative Complications; Pyrimidines; Skin; Transplantation, Homologous; Triazoles; Voriconazole	2006
Prophylaxis and aspergillosis--has the principle been proven? The New England journal of medicine, 2007, Jan-25, Volume: 356, Issue:4 Topics: Antifungal Agents; Aspergillosis; Fluconazole; Graft vs Host Disease; Humans; Itraconazole; Mycoses; Neutropenia; Opportunistic Infections; Triazoles	2007
Differential requirement for a cellular type-1 immune response in tumor-associated versus alloantigen-targeted GvT effects. Transplantation, 2007, Feb-15, Volume: 83, Issue:3 Topics: Animals; Antigens, Neoplasm; Cell Proliferation; Cytokines; Graft vs Host Disease; Graft vs Tumor Effect; Isoantigens; Mice; Mice, Inbred Strains; Quinolines; Th1 Cells; Triazoles; Tumor Cells, Cultured	2007
Posaconazole prophylaxis in hematologic cancer. The New England journal of medicine, 2007, May-24, Volume: 356, Issue:21 Topics: Antifungal Agents; Bilirubin; Chemical and Drug Induced Liver Injury; Fluconazole; Graft vs Host Disease; Humans; Liver Diseases; Mycoses; Transaminases; Triazoles	2007
[Breakthrough pulmonary mucormycosis during voriconazole treatment after reduced-intensity cord blood transplantation for a patient with acute myeloid leukemia]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2007, Volume: 48, Issue:5 Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Cord Blood Stem Cell Transplantation; Echinocandins; Fatal Outcome; Graft vs Host Disease; Humans; Immunocompromised Host; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Lipopeptides; Lipoproteins; Lung Diseases, Fungal; Male; Micafungin; Middle Aged; Mucormycosis; Peptides, Cyclic; Pyrimidines; Transplantation Conditioning; Triazoles; Voriconazole	2007
Breakthrough Scedosporium prolificans infection while receiving voriconazole prophylaxis in an allogeneic stem cell transplant recipient. Transplant infectious disease : an official journal of the Transplantation Society, 2007, Volume: 9, Issue:3 Topics: Antifungal Agents; Drug Synergism; Graft vs Host Disease; Humans; Immunocompromised Host; Immunosuppression Therapy; Male; Middle Aged; Mycetoma; Naphthalenes; Pyrimidines; Scedosporium; Stem Cell Transplantation; Terbinafine; Triazoles; Voriconazole	2007
Effect of calcineurin inhibitors on posaconazole blood levels as measured by the MVista microbiological assay. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:2 Topics: Antifungal Agents; Calcineurin Inhibitors; Cyclosporine; Drug Interactions; False Positive Reactions; Graft vs Host Disease; Humans; Immunosuppressive Agents; Microbiological Techniques; Sirolimus; Tacrolimus; Triazoles	2008
Voriconazole-induced blistering in the setting of graft versus host disease: A report of 2 patients. Journal of the American Academy of Dermatology, 2008, Volume: 58, Issue:3 Topics: Adult; Antifungal Agents; Blister; Bone Marrow Transplantation; Extremities; Female; Fusarium; Graft vs Host Disease; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole	2008
Prevention of lethal acute graft-versus-host disease in mice by oral administration of T helper 1 inhibitor, TAK-603. Blood, 2001, Feb-15, Volume: 97, Issue:4 Topics: Acute Disease; Administration, Oral; Animals; Bone Marrow Transplantation; Cytokines; Drug Evaluation, Preclinical; Female; Graft vs Host Disease; Immunosuppressive Agents; Intestines; Liver; Lymphocyte Count; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Quinolines; Radiation Chimera; Skin; Spleen; Th1 Cells; Transplantation, Homologous; Triazoles	2001